Risk factors for overweight and diabetes mellitus in residential psychiatric patients
- PMID: 22166752
- PMCID: PMC6444616
- DOI: 10.1159/000333420
Risk factors for overweight and diabetes mellitus in residential psychiatric patients
Abstract
Objective: To investigate the prevalence of and risk factors for overweight and diabetes mellitus in long-stay psychiatric inpatients.
Method: Statistical analysis of data collected from medical, laboratory, and pharmacy files.
Results: 80% of the 256 patients were suffering from schizophrenia or other psychotic disorders. The prevalence of diabetes mellitus was 15%. The prevalence of a disturbed glucose tolerance was 14%. Severe overweight (BMI > 30) was positively associated with the use of clozapine (odds ratio (OR) = 2.7; 95% confidence interval (CI): 1.31-5.75), but negatively with the diagnosis schizophrenia (OR = 0.4; 95% CI: 0.22-0.88). Diabetes mellitus was associated with severe overweight (OR = 3.5; 95% CI: 1.57-7.69). Caucasian patients were at a lower risk for diabetes mellitus (OR = 0.2; 95% CI: 0.08-0.54).
Conclusions: In residential psychiatric patients, diabetes mellitus is especially associated with overweight and non-Caucasian origin. In this survey, the use of clozapine was associated with overweight, but not directly with diabetes mellitus. Diabetes mellitus is highly prevalent, which calls for screening for diabetes mellitus at regular intervals.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.J Clin Psychiatry. 2005 Jul;66(7):900-6. doi: 10.4088/jcp.v66n0713. J Clin Psychiatry. 2005. PMID: 16013906
-
The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.Hum Psychopharmacol. 2011 Aug;26(6):392-6. doi: 10.1002/hup.1220. Epub 2011 Aug 8. Hum Psychopharmacol. 2011. PMID: 21826737
-
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.J Clin Psychiatry. 2005 Sep;66(9):1116-21. doi: 10.4088/jcp.v66n0905. J Clin Psychiatry. 2005. PMID: 16187768
-
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia.Br J Psychiatry Suppl. 2004 Apr;47:S67-71. doi: 10.1192/bjp.184.47.s67. Br J Psychiatry Suppl. 2004. PMID: 15056596 Review.
-
Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.J Clin Psychiatry. 2001;62 Suppl 23:39-44. J Clin Psychiatry. 2001. PMID: 11603884 Review.
Cited by
-
Participation and Outcomes among Disabled and Non-Disabled People in the Diabetes Pay-for-Performance Program.Healthcare (Basel). 2023 Oct 16;11(20):2742. doi: 10.3390/healthcare11202742. Healthcare (Basel). 2023. PMID: 37893816 Free PMC article.
-
The prevalence and clinical characteristics of diabetes mellitus in Chinese inpatients with chronic schizophrenia: a multicenter cross-sectional study.PeerJ. 2021 Nov 30;9:e12553. doi: 10.7717/peerj.12553. eCollection 2021. PeerJ. 2021. PMID: 34909279 Free PMC article.
-
A link among schizophrenia, diabetes, and asthma: Role of Ca2+/cAMP signaling.Brain Circ. 2020 Sep 30;6(3):145-151. doi: 10.4103/bc.bc_66_19. eCollection 2020 Jul-Sep. Brain Circ. 2020. PMID: 33210037 Free PMC article. Review.
-
Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.Singapore Med J. 2018 Sep;59(9):465-471. doi: 10.11622/smedj.2018020. Epub 2018 Feb 12. Singapore Med J. 2018. PMID: 29430576 Free PMC article.
-
Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides.Neuropsychiatr Dis Treat. 2017 Sep 27;13:2477-2487. doi: 10.2147/NDT.S145069. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 29026311 Free PMC article.
References
-
- Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999;156:1417–1420. - PubMed
-
- Bushe C, Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br J Psychiatry. 2004;184((suppl 47)):s67–s71. - PubMed
-
- Freeman H, Rodnick EH, Shakow D, Lebeaux T. The carbohydrate tolerance of mentally disturbed soldiers. Psychosom Med. 1944;6:311–317.
-
- Kohen D. Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry. 2004;184((suppl 47)):s64–s66. - PubMed
-
- Nimwegen LJM van, Storosum JG, Blumer RME, Allick G, Venema HW, de Haan L, Becker H, van Amelsvoort T, Ackermans MT, Fliers E, Serlie MJ, Sauerwein HP, Hepatic insulin resistance in antipsychotic naïve schizophrenic patients. stable isotope studies of glucose metabolism. J Clin Endocrinol Metab. 2008;93:572–577. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical